Solution for injections LARIFANS 2.5 mg/2 ml

Information renewed on 27.04.2021

Prescription medication – usage allowed only under doctor’s recommendations

Description

Solution for injections LARIFANS 2.5 mg/2 ml is an immunomodulating preparation with antiviral and antitumoral activity. Larifan is an interferon (IFN) inducer and the resulting biological effects may be caused by both the induced endogenous IFN and the direct activity of the dsRNA molecule.

Therapeutic indications:

– Recurrent herpes virus infection of any localization.

• Secondary immunodeficiency of any origin (caused by viral infections or anti-cancer medicaments etc.)

Dosage and application:

Larifan is injected subcutaneously. In case of a recurrent herpes virus infection the dose is 2.5 mg once a day, four times with 3 day intervals (1st, 5th, 9th, 12th day). Depending on the outcome , the course may be repeated after 6 months. For immunodeficiency treatment: dose rate 2.5 mg once a day, four times at weekly intervals, courses have to be repeated after a break of 1 or 2 months.

Advertising is intended for health care professionals only.

For full information about the medicine, see the Summary of Characteristics.

For inquires about the availability of Larifan 2.5 mg/ 2 ml prescription solution for injections contact us at:

GP Nord Ltd.

Mob. nr. 66064140

Email: info@gpnord.com

The advertiser: SIA “Larifāns” Kurbada iela 2b, Rīga, LV-1009. Information renewed on 27.04.2021